Regeneron, Eli Lily, and Astra Zeneca are among a number of major pharmaceutical companies testing neutralizing antibody cocktails to treat and prevent SARS-CoV-2 infection.
Dr. David Ho joins Meg Tirrell on CNBC’s “Healthy Returns: The Path Forward”. He discusses the SARS-CoV-2 pandemic and the work of his research team at the Aaron Diamond Aids Research Center.
A study recently published in Nature by Dr. David Ho and his team at Columbia University identified a mix of 19 different antibodies that target SARS-CoV-2, the coronavirus that causes COVID-19.
A panel of experts summarize advances in treatments and preventative strategies to address the SARS-CoV-2 pandemic and shre views on the dire situation in the US during the surge in infections.
In an interview with MSNBC’s Rachel Maddow, Dr. David Ho discussed new research into using antibodies from COVID-19 survivors in developing a treatment or vaccine against new coronavirus infections.
Researchers have identified a potent cocktail of antibodies that may help doctors treat Covid-19 infections and protect people at risk from falling ill with the disease.
Columbia researchers have isolated antibodies from COVID-19 patients that neutralize SARS-CoV-2 virus and could be used to treat patients or prevent infections.
Commissioner Adam Silver announced that the NBA will not restart its games although the pandemic is having a huge financial impact on the NBA, there remains too many unknowns to proceed otherwise.
ADARC has taken a leading role in clinical, applied, and basic research related to COVID-19 due to its extensive expertise in COVID-19 virology, clinical treatment, basic research, and drug discovery.
